Human Connection Makes Medications Work In Psychiatry

A medication can be the right choice and still never get taken. That’s not a science problem. It’s a human one, and it’s why we’re starting a conversation about the part of psychopharmacology that rarely shows up in a clinical trial: the lived experience of care.

I’m Dr. Saundra Jain, and I’m launching The Human Side of Psychopharmacology with one guiding belief: every encounter is therapeutic. After decades of work alongside psychiatric prescribers, therapists, patients, and families, I keep coming back to the same question: what helps treatment stick after the appointment ends? We talk about how trust is built, how hope is protected, and how uncertainty can be navigated without losing the person sitting across from us.

Mental health care is moving quickly toward precision medicine, digital tools, biomarkers, AI, and new therapies. I love that progress but I also worry about what gets lost when speed and innovation crowd out connection. The future of psychiatric care is both better treatments and better experiences of treatment, because engagement, shared decision making, and the clinician patient relationship shape adherence and outcomes.

You’ll hear real clinical stories that reveal the hidden gap between the treatment plan and real life: the patient who agrees with the diagnosis but never starts the medication because she’s scared, and the patient who stops an antidepressant in silence due to sexual side effects and embarrassment. If you want practical ways to make it safer for patients to tell the truth, ask the questions they can’t quite say, and keep hope alive when treatment gets hard, you’re in the right place. Subscribe, share this with a colleague, and leave a review so more clinicians can build care that patients actually experience as healing.

Transcript

Welcome And The Core Idea

Dr. Saundra Jain 0:06

Hi, and welcome to the human side of psychopharmacology. I'm Dr. Saundra Jain, and today I'd like to explore a simple but powerful idea. Every encounter is therapeutic. Every interaction with the patient matters. Whether you're a psychiatrist, a psychiatric nurse practitioner, physician associate, or another member of the mental health team, I'm so grateful you're here. You know, I've been thinking about launching this podcast for quite some time, and I am delighted you're joining me for this very first episode. Let's be honest, you have no shortage of interesting podcasts competing for your attention.

Why This Podcast Exists

Dr. Saundra Jain 1:00

So before we go any further, I'd like to answer three questions. One, why this podcast? Two, why now? And three, why does the human side of psychopharmacology deserve its own conversation? For more than three plus decades, I've had the privilege of sharing conference stages, classrooms, and conversations with psychiatrists, psychiatric nurse practitioners, physician associates, psychotherapists, and other mental health professionals across the country. Much of my work is focused on non-pharmacological interventions in mental health, things like psychotherapy, mindfulness meditation, exercise and sleep, motivational interviewing, social connection, nutrition, lifestyle approaches that support recovery, wellness, and resilience. And perhaps most importantly, the therapeutic relationship itself. I've always been fascinated by what happens when evidence-based treatments meet human connection. How do we help patients stay engaged? How do we build trust? How do we navigate uncertainty together? And how do we help patients feel seen, heard, and truly understood? I want you to know these questions have guided much of my professional life. And throughout the journey, psychiatric prescribers welcomed me into their community with remarkable warmth and generosity. Together, we've all had thousands of conversations about treatment, recovery, hope, resilience, post-traumatic growth, and healing. This podcast is in many ways my way of honoring those relationships. It's a way of continuing a conversation that we've been having for decades. A conversation about what helps treatment work, not just in clinical trials or on paper, but in the lives of real people. Because psychopharmacology, it doesn't happen in a vacuum. It happens in the context of relationships between clinicians and patients, between patients and the people who care about them, and within the realities of everyday life. And that's really the answer to the first question: why this podcast? Well, like I said, it's grounded in three plus decades of conversations with colleagues, patients, families, and students about what helps treatment work and what helps healing happen. Which

Why Now In A High Tech Era

Dr. Saundra Jain 4:35

brings us to the second question. Why now? I believe the answer to that question is rooted in this moment. As we all know, mental health care is rapidly changing. We are entering an era of precision medicine, digital tools, novel mechanisms of action, biomarkers, psychedelic assisted therapies, artificial intelligence, and extraordinary innovation. The list is very long, and I find all of this incredibly exciting. The future of psychiatric care is more promising now than at any point in my professional lifetime. But as our science advances, I believe something else becomes equally, if not more, important. We cannot lose sight of the human being sitting across from us. Yes, technology can inform our decisions. Science can guide the treatment. Innovation expands possibilities. But healing that still occurs within human relationships. Patients need hope. They need trust. They need someone who will lean in with curiosity, listen carefully, and remain present when treatment becomes difficult. In other words, the future of psychiatric care isn't simply about better treatments, it's also about better experiences of care.

What Helps Treatment Stick

Dr. Saundra Jain 6:36

And that brings me to the third question. Why does the human side of psychopharmacology deserve its own conversation, its own podcast? Well, for me, the answers have always come from my patients. I've always said they're our best teachers. Throughout my career, I've been so lucky to walk alongside patients as they navigate treatment, recovery, setbacks, and growth. And during this time, I found myself becoming increasingly curious about something. Not which medication worked best, but what happened after patients left the office. I wanted to know what helped them stay engaged, what helped them keep going when treatment was difficult. I wanted to better understand what builds trust or what made them lose hope. Somewhere along the way, I realized I was asking myself a different question. Not just what works, but what helps treatment stick? What helps people stay engaged when treatment becomes difficult? Why do they keep showing up? What helps them trust the process long enough to experience its benefits? Again and again, the answer pointed back to the same things: trust, hope, understanding, and the quality of the relationship itself. The science of treatment and the experience of treatment, well, they were working together to shape and influence outcomes. And that's when I realized the human side of psychopharmacology deserved its own conversation. I've had the privilege of hearing the rest of these stories. What happened after the appointment? What got in the way? What offered hope? What helped patients stay engaged in treatment? Those conversations led me to a question that I continue to explore. I said it earlier. What helps treatment stick? You know, sometimes the story of treatment looks very different once real life unfolds. Sometimes patients never start the medication. Sometimes they've stopped it weeks ago. They're frightened at times. They experience feeling hopeful. They also feel discouraged sometimes. And often what they remember most isn't the medication recommendation. It's the interaction. It's how they felt. Whether they felt heard, maybe rushed, or understood. Sitting with patients, I began to recognize something. Medication matters. Diagnosis matters. Science matters. But the relationship matters too. Psychopharmacology is one of the most important tools we have in psychiatric care. Lives are changed because of advancement in treatment. Families are restored. People regain functioning. Hope returns. Yet choosing the right treatment, that's only part of the equation. Patients need engagement. They need trust. They need to stay in treatment long enough to benefit. And they need to feel safe enough to share what's really happening.

When Fear Blocks Starting Medication

Dr. Saundra Jain 11:02

Let me give you an example. Years ago, a woman came to see me after a particularly difficult depressive episode. She'd recently met with her psychiatrist. The evaluation was thorough. The diagnosis was accurate. And the treatment plan, well, it made perfect sense. But several weeks later, when she came to see me, she told me something that she hadn't told anyone. She leaned forward and said, Sandra, I never started the medication. Now understand, she didn't question the diagnosis and she didn't argue with the treatment recommendation. She trusted it. She simply said, I was scared and I didn't know who to talk to. I want you to know I have never forgotten that. Treatment plan was right, but fear got in the way. What struck me most wasn't that she never started taking the medication. What got my attention was that no one knew she had carried this alone. She taught me something really important. Sometimes what our patients need most isn't more information about a medication or a treatment. They need help navigating what the medication or the intervention means to them. Sometimes they simply need reassurance or they need permission to ask the questions they're afraid to ask. And sometimes they need to know that someone like us that we will walk alongside them if things get difficult. That experience taught me that there's often a gap between the treatment plan and the treatment experience. The treatment plan happens in the office, but the treatment experience happens in the patient's life. Think about it, it's shaped by fears, expectations, family conversations, financial realities, past experiences, and questions patients may never ask out loud. So understanding that gap has really changed the way I think about psychiatric care. Because what happens between appointments can be just as important as what happens during them. Those moments matter. One of the most important influences on treatment outcomes often happens outside the clinical encounter, where treatment meets real life. Patients leave our offices. They're carrying much more than a diagnosis or a prescription. They're leaving with questions, with hopes, with past experiences that may shape how they're thinking about treatment. And sometimes they're carrying fears that they haven't shared with anyone. As clinicians, we don't always get to see those parts of the story. But as a practicing psychotherapist over these many years, I've had the honor and privilege of sitting with patients, hearing these stories. I've heard what they worried about once they got home. I've heard about the conversations they've had with their spouses, their family members, their friends. I've heard the reasons they never started a medication, the reasons they stopped a medication, or the reasons they simply lost confidence in a treatment plan. I'll say it again. The treatment plan begins in the office, but the treatment experience unfolds in our patients' lives. And understanding the difference really can change the way we think about care.

The Silent Side Effect Conversation

Dr. Saundra Jain 15:44

Here's another example. I once worked with a man who had been doing quite well on an antidepressant. His mood was improving, he was functioning better. And from the outside, it looked like treatment was really working. Then, seemingly out of nowhere, he stopped taking the medication. So I leaned in with curiosity and I asked him what happened. And there was a noticeable hesitation. But eventually he told me that he began experiencing sexual difficulties. And what struck me wasn't the side effect itself, it was what he believed it meant. He didn't realize that the problem could be related to the medication. Instead, he became convinced that something else was wrong with him. I remember it so clearly. He felt embarrassed, he was ashamed, and he was extremely uncomfortable bringing it up with his female prescriber. So he did what many of our patients do when they're frightened or confused. They say nothing. This patient quietly stopped the medication and he suffered in silence. Months later, when we finally talked about it, I remember thinking how differently that story might have unfolded. A simple conversation, a little education, an invitation to talk openly about side effects. Any one of these things might have changed the outcome. You know, it's experiences like this that remind me adherence isn't just about motivation. Sometimes it's about understanding. Sometimes it's about creating enough safety for our patients to talk about what's really happening. And sometimes it's about asking the question they may be too embarrassed to ask themselves. And sometimes those moments determine whether a patient stays engaged or drops out of treatment altogether. And because of that, every encounter matters.

What Patients Actually Remember

Dr. Saundra Jain 18:18

In future episodes, we're going to explore things like trust, adherence, shared decision making, difficult conversations, treatment resistance, hope and recovery, emerging psychedelic therapies, patient engagement, and the future of psychiatric care. We'll also have conversations with leading psychiatrists, physician associates, psychiatric nurse practitioners, researchers, therapists, and innovators. I want you to know my goal isn't simply to talk about treatment. My goal is to talk about the experience of treatment. Remember, those are not always the same thing. I've become fascinated by this simple question. What do patients actually remember? I'll tell you this: they rarely remember percentages from a clinical trial or the details of a medication discussion. And they rarely remember every option that was presented to them. But they do remember whether they felt respected, whether their clinician made eye contact, whether their concerns were welcomed or dismissed. They remember whether there was room for uncertainty. And perhaps most importantly, they remember if they felt a connection with their clinician. Those experiences become part of treatment. They influence adherence, hope, and outcomes. And that, my friends, is the human side of psychopharmacology. Let me take a moment and share a brief story to illustrate this. Recently, in gathering a patient's medication history, the patient told me, Sandra, I don't remember exactly what medication my clinician prescribed, but I do remember they didn't give up on me. They believed that I could get better, and that's what really helped me recover. Take a minute. Think about that. Of course the medication mattered. But what this patient remembered wasn't the medication or the details about the medication. It was hope and connection. The future of psychiatric treatment isn't science or humanity. It's both. In many ways. That's the human side of psychopharmacology. And that's why this podcast exists. To explore not only what we do as clinicians, but how we do it. I

A Closing Question For Clinicians

Dr. Saundra Jain 21:34

want to thank you for joining me for this inaugural episode of the human side of psychopharmacology with Dr. Saundra Jain. Before we close, I'll leave you with the question. What is one thing you can do this week to help a patient feel more seen and heard? Until next time, remember, the medication matters, the diagnosis matters, the evidence matters, but every encounter is therapeutic. And how we show up matters.